Aurora Health Care

Wauwatosa, Wisconsin 53266

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Indolent Non-Hodgkin's Lymphoma, Malignant Neoplasm of Breast, Triple Negative Breast Cancer

Studies at this site

• Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer — Stopped early
• Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer — Completed
• Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma — Stopped early